Dynavax Technologies | Ação





Ação Alterar Data
AbbVie USD 4.94B 22M 2025-09
Adma Biologics USD 196.67M 5.21M 2025-09
Amgen USD 6.22B 121M 2025-12
AstraZeneca USD 6.59B 126M 2025-09
Biogen USD 2.17B 41.3M 2025-12
BioMarin Pharmaceutical USD 1.38B 42M 2025-09
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Dynavax Technologies USD 73.29M 2.4M 2025-09
Gilead Sciences USD 1.78B 40M 2025-09
Glaxosmithkline GBP 6.12B 46M 2025-09
Merck USD 6.44B 157M 2025-09
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 69.3M 12.4M 2025-09
Novartis USD 6.42B 114M 2025-09
Pfizer USD 11.47B 201M 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Roche Holding CHF 7.6B 9M 2025-06
Sarepta Therapeutics USD 1.08B 83.13M 2025-09
TG Therapeutics USD 146.95M 8.25M 2025-09
Vertex Pharmaceuticals USD 1.63B 127.5M 2025-09


Dynavax Technologies Ação - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.